A possible explanation for the selective advantage of BDT in the NPC patients comes from the observation that the receptor activator of NF-kB (RANK), a key mediator of bone metastases, is highly expressed at the tissue level in 100% of metastatic lesions from NPC [25]. Here, TNFRSF11A is linked to nasopharyngeal carcinoma.